Jadart Tablet 0.5 mg (Dutasteride)

Adult dose

The recommended dose of this medicine is 1 tablet (0.5mg) once daily. Swallow this medicine whole without chewing or splitting it. This medicine may be taken with or without food. No dose adjustment is necessary in patients with renal impairment or elderly patients. Since there are no data on administration of this medicine to patients with hepatic impairment, the recommended dose of this medicine in patients with hepatic impairment has not been established.

This medication is absorbed through the skin, so women who are pregnant or may become pregnant should not touch or handle this medication. In particular, it should be avoided to touch broken or damaged pieces of this medication. Children under 18 years of age or women should not use this medication. Men planning to conceive should use this medication cautiously, as it may affect reproductive capacity, based on a doctor's judgment. Patients with urinary issues or liver function abnormalities should use this medication with caution, especially in cases with urinary obstruction symptoms. This medication is extensively metabolized in the liver, so it should be used with caution in patients with liver disorders. Patients taking strong CYP3A4 enzyme inhibitors for a long time may have increased blood concentration when used with this medication, so caution is advised. During the use of this medication, erectile dysfunction, decreased libido, ejaculation disorders, and other sexual dysfunctions may occur, which may persist even after stopping the medication. Additionally, breast-related adverse reactions such as gynecomastia and breast tenderness may occur. Patients receiving this medication should have their PSA levels checked regularly for prostate cancer screening, as this medication lowers PSA levels, requiring caution in interpreting test results. Blood donation should be avoided during the use of this medication, and a minimum of 6 months should pass after the last dose before blood donation is possible. There is no specific antidote for overdose, so appropriate supportive treatment should be administered according to symptoms. Keep this medication out of the reach of children and store it in its original container to prevent misuse or deterioration of quality. This medication is unlikely to affect driving or operating machinery, but caution is necessary as it may vary among individuals. In patients with heart failure, co-administration of this medication with other agents may increase the risk of heart failure, so careful observation is required. No significant drug interactions with several other medications have been reported; however, caution is needed when combined with certain drugs. This medication should not be used by pregnant women or nursing mothers, as it may have serious effects on the fetus. Even with prolonged use, sexual dysfunction or breast disorders may continue to occur, necessitating regular monitoring.

• erectile dysfunction
• decreased libido
• ejaculation disorder
• gynecomastia
• headache
• gastrointestinal discomfort and pain
• sexual dysfunction
• breast disorders
• dizziness
• heart failure

This medication should be stored in a tightly closed container to prevent air or moisture from entering. It is advisable to maintain a storage temperature between 1 to 30 degrees Celsius.

Appearance

Pale yellow oval film-coated tablet

Package unit

30 tablets (10 tablets/PTP x 3)